Georgia Senate Bill SB205

Georgia 2025-2026 Regular Session

• Introduced: 2/19/25
• Refer: 2/20/25

Caption

Insurance; pediatric autoimmune neuropsychiatric disorders; require coverage for healthcare services

Impact

The bill will have a notable impact on state laws governing health benefit policies by mandating coverage for PANDAS and PANS beginning January 1, 2026. It also applies to the state employees' health benefit plan, requiring similar coverage provisions. This represents a progressive step towards enhancing mental health care for children and acknowledges the importance of providing adequate treatment options for neuropsychiatric conditions. The requirement for coverage is based on evidence-based guidelines, illustrating a shift towards informed healthcare decision-making.

Summary

Senate Bill 205 aims to amend the Official Code of Georgia Annotated by requiring health benefit policies in the state to cover healthcare services for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) and pediatric acute onset neuropsychiatric syndrome (PANS). The bill establishes definitions for PANDAS and PANS, ensuring that treatment guidelines are aligned with nationally recognized clinical practice standards. This legislative effort acknowledges the need for specific coverage for these disorders, which can significantly impact children's health and wellbeing.

Conclusion

Overall, SB205 seeks not only to enhance access to necessary healthcare services for affected pediatric populations but also emphasizes the necessity for state laws to evolve in response to emerging health priorities. By establishing clear guidelines for coverage, the bill aims to ensure that children facing these challenging disorders receive appropriate and timely treatment, ultimately contributing to better health outcomes in Georgia.

Contention

Despite its intended benefits, SB205 may encounter opposition regarding its implications for health insurance costs and regulatory compliance. Some stakeholders may raise concerns about potential increases in premiums or the administrative burden on insurance providers to implement these changes. Furthermore, there may be debates over the extent of coverage for certain treatments, especially if certain procedures or medications are deemed experimental. However, the bill explicitly states that no special deductibles shall be imposed for these services, which may alleviate some financial concerns for families.